Human VIPR2(Vasoactive intestinal polypeptide receptor 2) ELISA Kit

Unleash the potential of your VIPR2 research with our Human VIPR2 ELISA Kit (EH1767). This meticulously designed kit is tailored for precision and efficiency, ensuring accurate quantification of VIPR2 levels in human samples, thus promoting data integrity and trustworthiness.
Uncompromising Precision: The EH1767 kit guarantees the highest level of precision and accuracy in quantifying VIPR2, fortifying the reliability and integrity of your research data.
Wide Detection Range: With the capacity to accommodate a wide range of sample concentrations, it is suitable for various research applications.
User-Friendly Interface: The kit simplifies laboratory procedures with clear and intuitive protocols, optimizing the research process and user experience.
Efficiency in Time Management: Engineered for efficiency, it minimizes laboratory work time, ensuring the rapid generation of research results and enhancing overall research productivity.

Product Name

Human VIPR2(Vasoactive intestinal polypeptide receptor 2) ELISA Kit

Alias

VIPR2 ELISA Kit, Vasoactive intestinal polypeptide receptor 2 ELISA Kit, VIP-R-2 ELISA Kit, VPAC2 ELISA Kit, Helodermin-preferring VIP receptor ELISA Kit, Pituitary adenylate cyclase-activating polypeptide type III receptor ELISA Kit, PACAP type III receptor ELISA Kit, PACAP-R-3 ELISA Kit, PACAP-R3 ELISA Kit, VIP2R ELISA Kit

Detection Method

Sandwich ELISA, Double Antibody

Application

VIPR2 ELISA Kit allows for the in vitro quantitative determination of VIPR2 concentrations in serum, plasma, tissue homogenates and other biological fluids.

Size

96T

Range

0.156-10ng/ml

Sensitivity

< 0.094ng/ml

Species

Human

UniProt ID

P41587

Standard Curve

Storage

2-8 ℃ for 6 months

Recovery

Matrices listed below were spiked with certain level of VIPR2 and the recovery rates were calculated by comparing the measured value to the expected amount of VIPR2 in samples.

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of VIPR2 and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

CV(%)

Intra-Assay: CV<8%

Inter-Assay: CV<10%

Note

For Research Use Only